Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

380 ARTÍCULOS , VIENDO DEL 196 AL 210

Spore powder of Ganoderma lucidum for the treatment of Alzheimer disease: A pilot study

Wang GH, Wang LH, Wang C, Qin LH.

Medicine (Baltimore). 2018 May;97(19):e0636. doi: 10.1097/MD.0000000000010636.

The Impact of a Long-Term Rivastigmine and Donepezil Treatment on All-Cause Mortality in Patients With Alzheimer's Disease

Kazmierski J, Messini-Zachou C, Gkioka M, Tsolaki M.

Am J Alzheimers Dis Other Demen. 2018 Sep;33(6):385-393. doi: 10.1177/1533317518775044. Epub 2018 May 9.

Passive Aβ Immunotherapy: Current Achievements and Future Perspectives

Schilling S, Rahfeld JU, Lues I, Lemere CA.

Molecules. 2018 May 3;23(5):1068. doi: 10.3390/molecules23051068.

Network Medicine for Alzheimer's Disease and Traditional Chinese Medicine

Jarrell JT, Gao L, Cohen DS, Huang X.

Molecules. 2018 May 11;23(5):1143. doi: 10.3390/molecules23051143.

Alzheimer's Disease, Dendritic Spines, and Calcineurin Inhibitors: A New Approach?

O'Neal MA, Stallings NR, Malter JS.

ACS Chem Neurosci. 2018 Jun 20;9(6):1233-1234. doi: 10.1021/acschemneuro.8b00213. Epub 2018 May 14.

A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease

Jalili-Baleh L, Babaei E, Abdpour S, Nasir Abbas Bukhari S, Foroumadi A, Ramazani A, Sharifzadeh M, Abdollahi M, Khoobi M.

Eur J Med Chem. 2018 May 25;152:570-589. doi: 10.1016/j.ejmech.2018.05.004. Epub 2018 May 7.

The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease

Creese B, Da Silva MV, Johar I, Ballard C.

Expert Rev Neurother. 2018 Jun;18(6):461-467. doi: 10.1080/14737175.2018.1476140. Epub 2018 May 21.

Cholinesterase targeting by polyphenols: A therapeutic approach for the treatment of Alzheimer's disease

Jabir NR, Khan FR, Tabrez S.

CNS Neurosci Ther. 2018 Sep;24(9):753-762. doi: 10.1111/cns.12971. Epub 2018 May 16.

Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors

Grossberg GT, Alva G, Hendrix S, Ellison N, Kane MC, Edwards J.

Alzheimer Dis Assoc Disord. 2018 Jul-Sep;32(3):173-178. doi: 10.1097/WAD.0000000000000261.

Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs

Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Chougule MB, Shoyele SA, Alexander A.

J Control Release. 2018 Jul 10;281:139-177. doi: 10.1016/j.jconrel.2018.05.011. Epub 2018 May 24.

Marine derived bioactive compounds for treatment of Alzheimer's disease

Lakshmi S, Prakash P, Essa MM, Qoronfleh WM, Akbar M, Song BJ, Kumar S, Elumalai P.

Front Biosci (Elite Ed). 2018 Jun 1;10(3):537-548. doi: 10.2741/E840.

Caffeine: A Potential Protective Agent Against Cognitive Decline in Alzheimer's Disease

Hussain A, Tabrez ES, Mavrych V, Bolgova O, Peela JR.

Crit Rev Eukaryot Gene Expr. 2018;28(1):67-72. doi: 10.1615/CritRevEukaryotGeneExpr.2018021391.

A comparative study of EPA-enriched ethanolamine plasmalogen and EPA-enriched phosphatidylethanolamine on Aβ(42) induced cognitive deficiency in a rat model of Alzheimer's disease

Che H , Li Q , Zhang T , Ding L , Zhang L , Shi H , Yanagita T , Xue C , Chang Y , Wang Y .

Food Funct. 2018 May 23;9(5):3008-3017. doi: 10.1039/c8fo00643a.

Peptides, Peptidomimetics, and Carbohydrate-Peptide Conjugates as Amyloidogenic Aggregation Inhibitors for Alzheimer's Disease

Ryan P, Patel B, Makwana V, Jadhav HR, Kiefel M, Davey A, Reekie TA, Rudrawar S, Kassiou M.

ACS Chem Neurosci. 2018 Jul 18;9(7):1530-1551. doi: 10.1021/acschemneuro.8b00185. Epub 2018 Jun 26.

The Impact of Cholinesterase Inhibitors with or without Memantine on Antipsychotic Prescribing

Blaszczyk AT, Mang BH, Garza H, Mathys M.

Consult Pharm. 2018 May 1;33(5):273-282. doi: 10.4140/TCP.n.2018.273..

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias